NEW YORK (GenomeWeb News) – Nanosphere today said that it plans to offer 10.5 million shares of its common stock at $2.40 per share in a public offering.

The offering is expected to bring in net proceeds of about $23.4 million. It has granted its underwriters a 30-day option to purchase up to 1.575 million additional shares of common stock to cover any overallotments. If the option is exercised, net proceeds are expected to be about $26.9 million.

The offering is expected to close on July 24.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.